NCT06420583

Brief Summary

The goal of this clinical trial is to compare between post operative pain and oral health related quality of life in participants receiving two treatments for first permanent mandibular molars with poor prognosis. Group I (Experimental group): Complete Pulpotomy with the use of MTA followed by stainless steel crown. Group II (Control group): Non-surgical extraction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 20, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 20, 2024

Status Verified

May 1, 2024

Enrollment Period

1.1 years

First QC Date

May 10, 2024

Last Update Submit

May 17, 2024

Conditions

Keywords

first permanent molarpulpotomyextractionoral health related quality of lifepost operative painvisual analog scale

Outcome Measures

Primary Outcomes (1)

  • Post operative pain

    will be measured using visual analog scale (VAS) The findings suggested that 100-mm VAS ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain.

    24 hours post operatively

Secondary Outcomes (1)

  • Oral health related quality of life

    12 months

Other Outcomes (1)

  • Clinical and radiographic success

    12 months

Study Arms (2)

Pulpotomy

EXPERIMENTAL

MTA Pulpotomy

Procedure: MTA pulpotomy

Extraction

ACTIVE COMPARATOR

Extraction

Procedure: Extraction

Interventions

MTA pulpotomyPROCEDURE

1. Application of rubber dam for isolation, then a standardized access cavity procedure will be performed using a large sterile round end bur in a high-speed handpiece with copious irrigation, a sharp spoon excavator will remove pulpal tissues to the orifice level, bleeding control in the pulp chamber will be achieved by using 5% sodium hypochlorite. 2. gentle condensation of MTA mix in the pulp chamber will be done by a wet sterile cotton pellet and then the rest of the pulp chamber will be filled with Glass Ionomer restoration. 3. The tooth will be restored with a stainless steel crown.

Also known as: vital pulp therapy
Pulpotomy
ExtractionPROCEDURE

After complete Anesthetic application in the affected area, non-surgical extraction will be done.

Extraction

Eligibility Criteria

Age8 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged between 8 years and 9.5 years.
  • Decayed Mandibular Permanent first molars.
  • Symptomatic Mandibular permanent first molar (caries-related pulpal symptoms or hypersensitivity relating to enamel hypo mineralization)

You may not qualify if:

  • Children who are not apparently healthy.
  • Lack of informed consent by the child patient's parent.
  • Patients who are allergic to any of the materials used in the procedure.
  • Unable to attend follow-up visits.
  • Refusal of participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

May 10, 2024

First Posted

May 20, 2024

Study Start

November 1, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

May 20, 2024

Record last verified: 2024-05

Locations